In the present study, we investigated the signaling pathways implicated in the induction of apoptosis by two modified
nucleosides, 5-phenylselenyl-methyl-2'-deoxyuridine (PhSe-T) and 5-methylselenyl-methyl-2'-deoxyuridine (MeSe-T), using human
cancer cell lines. The induction of apoptosis was associated with proteolytic activation of
caspase-3 and -9, PARP cleavage, and decreased levels of IAP family members, including c-IAP-1 and c-IAP-2, but had no effect on XIAP and
survivin. PhSe-T and MeSe-T also enhanced the activities of
caspase-2 and -8, Bid cleavage, and the conformational activation of Bax. Additionally,
nucleoside derivative-induced apoptosis was inhibited by the selective inhibitors of
caspase-2, -3, -8, and -9 and also by si-RNAs against
caspase-2, -3, -8, and -9; however, inhibition of
caspase-2 and -3 was more effective at preventing apoptosis than inhibition of
caspase-8 and -9. Moreover, the inhibition of
caspase-2 activation by the pharmacological inhibitor
z-VDVAD-fmk or by the knockdown of
protein expression using
siRNA suppressed
nucleoside derivative-induced
caspase-3 activation, but not vice versa. PhSe-T and MeSe-T also induced a Δψ(m) loss via a CsA-insensitive mechanism, ROS production, and DNA damage, including strand breaks. Moreover, ROS scavengers such as NAC,
tiron, and
quercetin inhibited
nucleoside derivative-induced ROS generation and apoptosis by blocking the sequential activation of
caspase-2 and -3, indicating the role of ROS in caspase-2-mediated apoptosis. Taken together, these results indicate that
caspase-2 acts upstream of
caspase-3 and that
caspase-2 functions in response to DNA damage in both PhSe-T- and MeSe-T-induced apoptosis. Our results also suggest that ROS are critical regulators of the sequential activation of
caspase-2 and -3 in
nucleoside derivative-treated
cancer cells.